Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) has been assigned an average recommendation of "Buy" from the ten research firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, seven have given a buy rating and two have given a strong buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $134.22.
Several research analysts have weighed in on the stock. StockNews.com upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Friday, January 24th. JMP Securities started coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an "outperform" rating and a $150.00 target price for the company. Citizens Jmp upgraded shares of Addus HomeCare to a "strong-buy" rating in a research report on Monday, December 16th. Oppenheimer increased their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th.
View Our Latest Report on Addus HomeCare
Insider Activity at Addus HomeCare
In related news, CEO R Dirk Allison sold 12,500 shares of the firm's stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares of the company's stock, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 39,750 shares of company stock valued at $4,930,750 over the last three months. 4.60% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in the business. Summit Place Financial Advisors LLC raised its stake in shares of Addus HomeCare by 0.9% during the fourth quarter. Summit Place Financial Advisors LLC now owns 9,410 shares of the company's stock worth $1,180,000 after acquiring an additional 80 shares in the last quarter. Janney Montgomery Scott LLC raised its stake in shares of Addus HomeCare by 0.9% during the fourth quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock worth $1,340,000 after acquiring an additional 91 shares in the last quarter. Alliancebernstein L.P. raised its stake in shares of Addus HomeCare by 0.5% during the fourth quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock worth $2,465,000 after acquiring an additional 91 shares in the last quarter. New York State Teachers Retirement System grew its holdings in shares of Addus HomeCare by 1.2% in the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company's stock worth $1,132,000 after purchasing an additional 100 shares during the last quarter. Finally, Equitable Trust Co. grew its holdings in shares of Addus HomeCare by 2.2% in the third quarter. Equitable Trust Co. now owns 4,825 shares of the company's stock worth $642,000 after purchasing an additional 106 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.
Addus HomeCare Trading Down 2.9 %
ADUS traded down $3.29 during trading on Thursday, reaching $108.78. 99,737 shares of the company's stock were exchanged, compared to its average volume of 159,654. Addus HomeCare has a one year low of $85.94 and a one year high of $136.72. The stock has a market capitalization of $1.97 billion, a PE ratio of 24.82, a price-to-earnings-growth ratio of 1.46 and a beta of 1.00. The firm has a fifty day moving average price of $125.35 and a two-hundred day moving average price of $126.81.
About Addus HomeCare
(
Get Free ReportAddus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.